SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-20-021871
Filing Date
2020-08-13
Accepted
2020-08-13 16:09:13
Documents
1
Group Members
PETR KELLNERPPF GROUP N.V.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.6 TO SCHEDULE 13D ea125488-13da6ppf_autolus.htm SC 13D/A 76539
  Complete submission text file 0001213900-20-021871.txt   78199
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Subject) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90550 | Film No.: 201099382
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address STRAWINSKYLAAN 933 AMSTERDAM P7 1077XX
Business Address STRAWINSKYLAAN 933 AMSTERDAM P7 1077XX 31(0) 20 8813120
PPF Capital Partners Fund B.V. (Filed by) CIK: 0001788140 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7
Type: SC 13D/A